Now that the Abbott Freestyle Libre has received FDA clearance, Abbott and Dexcom will be forced into tight competition in the US market. On Dexcom’s third quarter call, CEO Kevin Sayer spent some ...
A multicenter clinical trial comparing the Dexcom G7 and FreeStyle Libre 3 continuous glucose monitors found the Libre 3 more accurate across all glucose ranges. Libre 3 recorded a lower mean absolute ...
In December, online rumors hinted at the fact that Dexcom may be planning to sunset its G6 CGM sensor model. The company has now started to notify patients of the discontinuation plan. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results